Clinical comparative study of sodium valproate separately combined with ziprasidone and olanzapine in the treatment of bipolar disorder type Ⅰ
10.3760/cma.j.issn.1008-6706.2018.08.027
- VernacularTitle:丙戊酸钠分别与齐拉西酮和奥氮平联用治疗Ⅰ型双相情感障碍临床对比研究
- Author:
Jun′er LE
1
;
Jianlin WANG
;
Mintao ZHANG
Author Information
1. 舟山市第二人民医院心身病区
- Keywords:
Bipolar disorder;
Sodium valproate;
Ziprasidone;
Olanzapine
- From:
Chinese Journal of Primary Medicine and Pharmacy
2018;25(8):1056-1058
- CountryChina
- Language:Chinese
-
Abstract:
Objective To compare the clinical effects of sodium valproate separately combined with ziprasi -done and olanzapine in the treatment of bipolar disorder type Ⅰ .Methods 100 patients with bipolar disorder type Ⅰ were chosen.According to the digital table ,the patients were randomly divided into two groups ,including A group (50 children) with olanzapine and B group (50 children) with ziprasidone on the basis of sodium valproate .The clinical effects,the BRMS score,digit symbol scores,TMT A/B scores,WCST score and TOH cognitive function scores before and after treatment of the two groups were compared .Results The total effective rates of A group and B group were 88.00％,92.00％,respectively.There was no statistically significant difference in clinical effects between the two groups(χ2 =8.14,P<0.05).The BRMS scores of both two groups after treatment were significantly lower than before treatment(t=3,74,4.06,all P<0.05).There was no statistically significant difference in BRMS score after treatment between the two groups (t =0.89,P >0.05).The digit symbol scores,WCST score and TOH cognitive function scores of B group after treatment were significantly higher than those of A group and before treatment ( t=3.17,4.03,3.96,3.54,2.86,3.81,4.66,4.29,3.81,3.43,all P<0.05).The TMT A/B scores of B group after treatment were significantly lower than those of A group and before treatment ( t=3.82,4.82,4.55,4.09,3.83,all P<0.05).Conclusion Sodium valproate separately combined with ziprasidone and olanzapine in the treatment of bipolar disorder type I possess the same clinical effects in manic symptoms relief ,and sodium valproate combined with ziprasidone can effectively promote the recovery process of cognitive function damage and improve the clinical prognosis for long-term.
